Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CATB

Catabasis Pharmaceuticals

$5.27

0.02 (0.38%)

08:28
11/08/19
11/08
08:28
11/08/19
08:28
Recommendations
Catabasis Pharmaceuticals analyst commentary at Oppenheimer »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATB

Catabasis Pharmaceuticals

$5.25

-0.08 (-1.50%)

08:10
11/07/19
11/07
08:10
11/07/19
08:10
Earnings
Catabasis Pharmaceuticals reports Q3 EPS (56c), consensus (64c) »

"We have made…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

Over a month ago
CATB

Catabasis Pharmaceuticals

$4.80

(0.00%)

04:55
10/17/19
10/17
04:55
10/17/19
04:55
Conference/Events
Catabasis Pharmaceuticals management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CATB

Catabasis Pharmaceuticals

$4.92

-0.26 (-5.02%)

07:07
10/14/19
10/14
07:07
10/14/19
07:07
Conference/Events
Catabasis Pharmaceuticals management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CATB

Catabasis Pharmaceuticals

$4.76

-0.09 (-1.86%)

15:22
10/06/19
10/06
15:22
10/06/19
15:22
Hot Stocks
Catabasis Pharmaceuticals presents findings from MoveDMD trial of Edasalonexent »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CATB

Catabasis Pharmaceuticals

$5.31

-0.09 (-1.67%)

16:05
09/30/19
09/30
16:05
09/30/19
16:05
Hot Stocks
Catabasis completes enrollment for Phase 3 PolarisDMD trial of edasalonexent »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATB

Catabasis Pharmaceuticals

$5.29

0.09 (1.73%)

08:17
09/26/19
09/26
08:17
09/26/19
08:17
Hot Stocks
Catabasis Pharmaceuticals, Jain Foundation announce CAT-1004 collaboration »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATB

Catabasis Pharmaceuticals

$5.20

-0.5 (-8.77%)

08:02
09/25/19
09/25
08:02
09/25/19
08:02
Hot Stocks
Catabasis Pharmaceuticals appoints Andrew Komjathy Chief Commercial Officer »

Catabasis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CATB

Catabasis Pharmaceuticals

$6.23

0.05 (0.81%)

, EVFM

Evofem

$5.29

-0.225 (-4.08%)

08:30
09/06/19
09/06
08:30
09/06/19
08:30
Options
Seven new option listings and two option delistings on September 6th »

New option listings for…

CATB

Catabasis Pharmaceuticals

$6.23

0.05 (0.81%)

EVFM

Evofem

$5.29

-0.225 (-4.08%)

TCRR

TCR2 Therapeutics

$19.84

0.96 (5.08%)

XPEL

XPEL

$11.53

0.4 (3.59%)

YCBD

cbdMD

$3.95

-0.01 (-0.25%)

CCIH

ChinaCache

$0.89

(0.00%)

SDLP

Seadrill Partners

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 09

    Sep

Over a quarter ago
CATB

Catabasis Pharmaceuticals

$6.52

-0.12 (-1.81%)

08:06
08/08/19
08/08
08:06
08/08/19
08:06
Earnings
Catabasis Pharmaceuticals reports Q2 EPS (62c), consensus (61c) »

"Thanks to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.